Navigation Links
Miami’s Preferred Cord Blood Laboratory, GeneCell International, Partakes in North Shore Medical Center and Hialeah Hospital’s OB/GYN Symposium
Date:9/20/2013

Miami, Florida (PRWEB) September 20, 2013

The OB/GYN Symposium will be focused on the areas of cancer and genetic screening, management of cervical dysplasia, fetal neural protection, and other related topics in the field of OB/GYN. The symposium is set to take place on Saturday, September 21, 2013, from 7 a.m. to 7 p.m. at the Doral Golf Resort & Spa, located at 4400 N.W. 87th Avenue, Miami, FL 33178.

“We believe in offering the best support to the medical community, this will ensure doctors will provide parents with the best and most up-to-date information so they are able to make an informed decision on preserving their child’s stems cells,” said GeneCell’s Physician’s Relation’s Manager, Lisa Reyes Munoz.

GeneCell International specializes in the collection, transport, processing and cryogenic storage of adult stem cells from various sources including; umbilical cord blood, cord tissue segment (known as Wharton’s Jelly), dental pulp (teeth) and adipose tissue (fat) that can later be used to treat a variety of diseases. The laboratory is also involved in scientific research and development with a range of stem cells from various adult tissues. The facility is governed and inspected by the FDA, Florida Department of Health and several other regulating bodies to ensure the safety of these cellular therapies.

“For me, the opportunity for meeting and discussing the scientific aspect of these life-saving cells with the physicians is rewarding," added GeneCell’s Laboratory Manager, Priscilla Pages.

Cord blood is rich in stem cells and there are fewer risks for the recipient’s immune system to reject the cells, because certain immune cells found in the cord blood are not mature. Cord blood can be used to treat the child from whom the blood was collected as well as some first-degree relatives who are a close genetic match, such as family members. Additionally, patients can get the treatment in about three weeks - as opposed to six to eight for bone marrow from an adult donor.

“Informing all attending physicians on the importance of cord blood banking and the differences between these non-controversial cells is imperative,” added GeneCell’s Director of Operations, Jose Cirino

GeneCell International presently conducts monthly cord blood workshops at its Miami, West Kendall, facility in order to further educate and update the community on the advancements of stem cells, both hematopoietic (cord) and mesenchymal (cord tissue, dental and adipose).

Umbilical cord blood preservation is a process by which blood is collected from the umbilical cord of a newborn baby and is stored cryogenically in a specially-designated bank. According to the National Marrow Donor Program, cord blood contains cells that can be transfused to a patient to treat various diseases, including lymphoma and leukemia. Currently, there are approximately 80 diseases and the list of illnesses utilizing cord blood stem cells, as a treatment, continues to grow.

GeneCell International, LLC is a trusted provider in the collection, processing and storage of adult stem cells from various sources which have the potential to treat a variety of diseases and disorders. Headquartered in Miami, Florida and a local office in Central Florida and international offices or laboratories in Colombia, Costa Rica, Dominican Republic, Honduras, India, Peru, Puerto Rico, and Venezuela, GeneCell operates state of the art laboratories and storage facilities for the cord blood and dental pulp of thousands of clients. For more information and to learn more about cord blood banking, dental pulp or other GeneCell services, please visit our website at http://www.GeneCell.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11143568.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GeneCell International, Miami’s Preferred Cord Blood Laboratory, is Pleased to Announce That July is National Cord Blood Awareness Month
2. CellerateRX® Added to List of Preferred Products for Golden Living Healthcare Network
3. BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends
4. Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
5. BioMed Realty Trust Declares Second Quarter 2012 Common Stock And Preferred Stock Dividends
6. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
7. University of Colorado Cancer Center Study Shows the Preferred Feeding Method is not the Medically Best in Malnourished Pediatric Cancer Patients
8. Despite Lucentiss Recent Expanded Label for Diabetic Macular Edema, Avastin Remains the Preferred Intravitreal Therapy for Diabetic Macular Edema in the United States
9. FindTheBest Helps Parents Find Cord Blood Banks
10. Cord Blood America Announces DTCC Removes "Chill" Imposed in December 2010
11. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of ...
(Date:2/23/2017)... Minn. , Feb. 23, 2017  Imanis ... new product line of oncolytic vaccinia viruses for ... Corporation as part of Genelux,s proprietary, vaccinia virus-based ... are excited to enter into a partnership with ... selected oncolytic vaccinia viruses for use in research," ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, ... partnership with Compass Research . GGI's mission is to advance global health and ... child in need in honor of each clinical trial volunteer. The vision of GGI ...
(Date:2/22/2017)... -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused ... for companion animals, will host a live conference call on ... financial results from the fourth quarter and full year ended ... may access the audio webcast or use the ... ...
Breaking Biology Technology:
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
Breaking Biology News(10 mins):